FdaApplication
NDA 214962
Identifiers
- fda_app_no: NDA214962
Properties
| Property | Value |
|---|---|
| applicant_name | CYCLE PHARMACEUTICALS LTD |
| application_type | NDA |
| approval_date | 2021-12-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TASCENSO ODT | FINGOLIMOD LAURYL SULFATE | EQ 0.25MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| TASCENSO ODT | FINGOLIMOD LAURYL SULFATE | EQ 0.5MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
2 products